NDC codes

404917 NDC codes with hospital pricing data in the network.

• NDC 73070-0203-10 — Insulin aspart protamine and aspart 70/30 penAI (46 hospitals, 29–290 samples)
• NDC 00409-6778-05 — Lorazepam 2 mg/mL injectionAI (47 hospitals, 101–290 samples)
• NDC 09990-8915-00 — EPINEPHRINE 1 MG/ML INJECTION KITAI (22 hospitals, 29–290 samples)
• NDC 409710167 — Sodium chloride 0.9% IV solutionAI (84 hospitals, 154–289 samples)
• NDC 63323-0609-01 — Enoxaparin sodium 120 mg/0.8 mL prefilled syringeAI (96 hospitals, 262–289 samples)
• NDC 00065-0702-12 — Atropine 1% eye drops, 2 mLAI (26 hospitals, 271–289 samples)
• NDC 00085-1197-01 — MOMETASONE 17GM NAS SPRY (7 hospitals, 271–289 samples)
• NDC 00087-6071-11 — metFORMIN 1000 mg Tab (5 hospitals, 271–289 samples)
• NDC 00093-5401-89 — Omega-3 fish oil capsules, 1000 mgAI (47 hospitals, 271–289 samples)
• NDC 00143-1764-01 — Trihexyphenidyl 2 mg tabletsAI (32 hospitals, 271–289 samples)
• NDC 00603-2435-21 — Benztropine 2 mg oral tabletAI (52 hospitals, 271–289 samples)
• NDC 00941-0424-38 — Dianeal 1.5% PD Low Ca Soln 2500 mL (2 hospitals, 271–289 samples)
• NDC 00941-0430-53 — Peritoneal dialysis solution with 2.5% dextroseAI (119 hospitals, 271–289 samples)
• NDC 00998-0354-15 — Tropicamide 0.5% Ophth Sol (7 hospitals, 271–289 samples)
• NDC 49452-0042-01 — acetic acid 3%, 60 mL Soln (3 hospitals, 271–289 samples)
• NDC 70860-0781-01 — Glycopyrrolate 0.2 mg/mL injectionAI (123 hospitals, 117–288 samples)
• NDC 49281-0286-10 — Diphtheria, pertussis and tetanus vaccine for childrenAI (490 hospitals, 153–288 samples)
• NDC 00264-1101-55 — 5% dextrose in water, 500 mL bagAI (27 hospitals, 54–288 samples)
• NDC 00003-2188-11 — ABATACEPT 125 MG/ML SUBCUTANEOUS SYRINGEAI (82 hospitals, 54–288 samples)
• NDC 641619601 — Propofol intravenous emulsion, 1000 mg per 100 mLAI (10 hospitals, 198–288 samples)
• NDC 00409-7923-23 — Dextrose 5% in water intravenous solutionAI (32 hospitals, 234–288 samples)
• NDC 59676-0310-00 — Epoetin alfa injection, 10,000 units per mLAI (524 hospitals, 197–287 samples)
• NDC 63323-0140-10 — Cladribine injection, 10 mg per 10 mL IVAI (759 hospitals, 206–287 samples)
• NDC 2879959 — Insulin lispro pen, 3 mLAI (107 hospitals, 53–287 samples)
• NDC 71288-0414-92 — Glycopyrrolate injection 0.2 mg/mLAI (38 hospitals, 62–287 samples)
• NDC 59148-0018-70 — Aripiprazole extended-release 300 mg injectable suspensionAI (107 hospitals, 269–287 samples)
• NDC 72603-0188-01 — DEXAMETHASONE 2 MG TABLETAI (51 hospitals, 115–286 samples)
• NDC 10019-0943-25 — Cyclophosphamide 500 mg powder for IV solutionAI (80 hospitals, 169–286 samples)
• NDC 00641-6077-10 — Neostigmine 5 mg/5 mL injectionAI (26 hospitals, 214–286 samples)
• NDC 67457-0612-20 — Vancomycin enema (1 gram in saline)AI (49 hospitals, 115–286 samples)
• NDC 88888-0006-60 — HYDROMORPHONE 2 MG/ML INJECTION SOLUTION (1 hospital, 133–286 samples)
• NDC 72603-0139-01 — Thiamine (vitamin B1) 100 mg/mL injectionAI (186 hospitals, 42–285 samples)
• NDC 70842-0120-01 — Meropenem-vaborbactam 2 gram vialAI (407 hospitals, 267–285 samples)
• NDC 00536-1161-37 — Dextromethorphan-guaifenesin extended-release tabletAI (200 hospitals, 213–285 samples)
• NDC 66794-0155-02 — Baclofen intrathecal solution, 20 mL vialAI (246 hospitals, 168–285 samples)
• NDC 59011-0430-10 — Oxycodone extended-release tablets 30 mgAI (51 hospitals, 258–285 samples)
• NDC 143962201 — Labetalol 5 mg/mL solution, 20 mL vialAI (152 hospitals, 123–285 samples)
• NDC 00264-9594-20 — Lidocaine 0.4% in dextrose IV solutionAI (185 hospitals, 69–285 samples)
• NDC 21922-0039-23 — Metronidazole 0.75% vaginal gelAI (164 hospitals, 213–285 samples)
• NDC 43547-0524-03 — Nebivolol 2.5 mg tabletsAI (134 hospitals, 213–285 samples)
• NDC 55150-0210-10 — Bivalirudin 250 mg IV powder for solutionAI (204 hospitals, 59–284 samples)
• NDC 16729-0275-67 — Bivalirudin 250 mg IV powder for solutionAI (243 hospitals, 59–284 samples)
• NDC 67457-0256-10 — Bivalirudin 250 mg IV powder for solutionAI (216 hospitals, 59–284 samples)
• NDC 31722-0203-20 — Lacosamide 200 mg intravenous injectionAI (215 hospitals, 41–284 samples)
• NDC 63323-0762-10 — Topotecan 4 mg injection vialAI (493 hospitals, 41–284 samples)
• NDC 60505-6101-04 — Bivalirudin injection 250 mgAI (76 hospitals, 59–284 samples)
• NDC 70594-0060-01 — Daptomycin 500 mg intravenous vialAI (41 hospitals, 140–284 samples)
• NDC 72266-0242-05 — Lacosamide 200 mg intravenous solutionAI (149 hospitals, 41–284 samples)
• NDC 00781-3158-94 — Bivalirudin 250 mg vialAI (274 hospitals, 59–284 samples)
• NDC 713035102 — Prochlorperazine edisylate injection, 10 mgAI (48 hospitals, 68–284 samples)